IPP Bureau

Moderna reshapes leadership and ops model as it pushes into oncology, rare disease
Moderna reshapes leadership and ops model as it pushes into oncology, rare disease

By IPP Bureau - June 18, 2026

CEO Stéphane Bancel framed the changes as essential to scaling the business

Siegfried opens major API manufacturing facility in Germany
Siegfried opens major API manufacturing facility in Germany

By IPP Bureau - June 18, 2026

The expansion adds 100 m³ of reactor capacity, significantly strengthening Siegfried’s position among the world’s leading CDMOs for small-molecule drug substances

Pharma PLI scheme attracted Rs. 42,694 crore investments, created 1.13 lakh jobs in 6 years: Govt
Pharma PLI scheme attracted Rs. 42,694 crore investments, created 1.13 lakh jobs in 6 years: Govt

By IPP Bureau - June 18, 2026

As per the Department of Pharmaceuticals, the sector has expanded its reach across the country while strengthening domestic production capabilities and innovation

Suven reports positive Phase 2b results for Ropanicant in major depressive disorder
Suven reports positive Phase 2b results for Ropanicant in major depressive disorder

By IPP Bureau - June 18, 2026

Suven has already begun planning a global Phase 3 registrational program for MDD based on the results

AbbVie's Allergan wins FDA nod for first injectable targeting neck lines
AbbVie's Allergan wins FDA nod for first injectable targeting neck lines

By IPP Bureau - June 18, 2026

The newly approved treatment, SKINVIVE by JUVÉDERM, is now the first and only hyaluronic acid injectable cleared specifically for improving neck appearance

Bayer seals $300 million Perfuse deal
Bayer seals $300 million Perfuse deal

By IPP Bureau - June 18, 2026

Secures high-stakes glaucoma drug in up to $2.45b bet on eye care pipeline

Avio Smart appoints Sandeep Pandya to lead global healthcare expansion
Avio Smart appoints Sandeep Pandya to lead global healthcare expansion

By IPP Bureau - June 18, 2026

Veteran healthcare executive to drive international growth, strategic partnerships, and global commercialization of the company's molecular diagnostics portfolio

Lupin secures 180-day exclusivity for generic Azilsartan Medoxomil tablets in U.S. market
Lupin secures 180-day exclusivity for generic Azilsartan Medoxomil tablets in U.S. market

By IPP Bureau - June 18, 2026

Company introduces bioequivalent version of Edarbi for hypertension treatment following U.S. FDA approval; product recorded annual U.S. sales of USD 53.5 million

Brinton Pharma appoints Sathya Narayanan as CEO – India and JPAC
Brinton Pharma appoints Sathya Narayanan as CEO – India and JPAC

By IPP Bureau - June 18, 2026

Industry veteran with over two decades of experience to lead expansion across India, South Asia, Southeast Asia, and other high-growth healthcare markets

ARScience Biotherapeutics appoints Gustavo Mahler as CEO
ARScience Biotherapeutics appoints Gustavo Mahler as CEO

By IPP Bureau - June 17, 2026

Mahler brings more than 20 years of leadership experience spanning cell therapy, biopharmaceutical development, manufacturing, and global business management

Glenmark launches generic Methylene Blue Injection in US market
Glenmark launches generic Methylene Blue Injection in US market

By IPP Bureau - June 17, 2026

Generic launch targets a US$19 million market in United States, strengthening Glenmark’s institutional and injectable product portfolio in North America

JLN Medical College launches robotic surgery programme in Rajasthan
JLN Medical College launches robotic surgery programme in Rajasthan

By IPP Bureau - June 17, 2026

The launch event brought together policymakers, healthcare leaders, surgeons, and members of the medical fraternity to discuss the transformative role of robotic-assisted surgery

Can India become global clinical trials hub? Industry leaders to discuss road ahead on 19th June
Can India become global clinical trials hub? Industry leaders to discuss road ahead on 19th June

By IPP Bureau - June 17, 2026

Leading experts from AIIMS Kalyani, Syngene, Veeda Lifesciences, Lambda Therapeutic, DNDi, JSS Medical, KIHT, InoRx, ISCR and SIRO Clintech to discuss India’s readiness as preferred clinical research destination

BD India and HOPE Foundation empower 264 youth through skill development initiative
BD India and HOPE Foundation empower 264 youth through skill development initiative

By IPP Bureau - June 17, 2026

Partnership enters its ninth year after training over 2,200 young people and enabling employment for more than 1,750 beneficiaries through nursing assistant and digital skills programs

Jaslok Hospital performs advanced robotic surgery to remove early rectal cancer
Jaslok Hospital performs advanced robotic surgery to remove early rectal cancer

By IPP Bureau - June 17, 2026

Robotic TAMIS procedure helps 75-year-old patient avoid rectum removal and permanent stoma, enabling faster recovery and preserving quality of life

Latest Stories

Interviews

Packaging